Benzinga | Sep 9, 2021 06:34AM EDT

KalVista Pharmaceuticals Q1 EPS $(0.66) Down From $(0.61) YoY

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.66) per share. This is a 8.2 percent decrease over losses of $(0.61) per share from the same period last year.